ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
ACT Brief: AI Partnerships, Global Trial Access, and a New Option for Menopause Symptoms
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness
ACT Brief Weekly Recap: Clinical Research Faces Funding Strain, Data Evolution, and a Shift in Outsourcing Models
Reimagining Clinical Operations Through Artificial Intelligence
ACT Brief Weekly Recap: AI Monitoring, Biotech Scaling, and Site Interoperability Lead This Week’s Top Stories
ACT Brief Weekly Recap: Data Innovation, Cybersecurity, and Contracting Bottlenecks in Clinical Trials
ACT Brief Weekly Recap: Partnerships, Site Networks, and AI Reshaping Clinical Trials
ACT Brief: Policy Shifts, FDA Inspections, and Tariffs Pose New Challenges for Clinical Trials
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
ACT Brief Episode 4: New Data on Trial Delays, Hybrid Payment Models, and Managing Complexity
ACT Brief Episode 3: Breaking Down Data Silos to Accelerate Clinical Trials
ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
Unifying Industry to Better Understand GCP Guidance
Improving Relationships and Diversifying the Site Selection Process
Reaching Diverse Patient Populations With Personalized Treatment Methods
Driving Diversity with the Integrated Research Model
AI in Clinical Trials - A Long, But Promising Road Ahead
Including Women of Childbearing Age in Clinical Research
Improving Engagement While Maintaining Data Integrity & Validity
Diversity in Clinical Trials: The Need to Take Action
Bringing the Clinical Trials Industry Together
Managing Digital Studies in the Current Landscape
Combining Awareness and Innovation
SCOPE EUROPE 2023 Recap
Bringing Innovation To The Clinic
Advancing Rare Disease Research and the Development of Targeted Therapies
Leveraging The Power Of AI
A Look at the Current State of Sites
Where Digital Health Technology Intersects With Pharma
AI Is The New Electricity
Building Clinical Trials With Trust
The Evolution of Early-phase Research
The Trust Factor In Data
Addressing The Gap Between Tech In Every Day Life Vs. Tech In Clinical Trials
Cell And Gene Therapy: Still On A Learning Curve
Clinical Studies Take Teamwork
Drug Development Agility with Safety First
Examining the Neurology/Neuromuscular Space
Data In Clinical Trials—How Did We Get Here And What’s Next?
Health Equity In Clinical Trials
next page